Revascularization strategy in acute coronary syndrome (ACS) is based on the ST segment deviation in the presenting electrocardiogram (ECG). ST segment elevation denotes total occlusion of culprit vessel and mandates early revascularization. Geroge et al. have studied 89 consecutive patients with chest pain and angiogram evidence of at least one totally occluded epicardial coronary vessel. Culprit artery prediction was attempted according to the available algorithms and correlated with the angiogram finding. [1, 2] All patients with total occlusion of left anterior descending (LAD) and right coronary artery had ST segment elevation whereas only 50% of patients with circumflex artery occlusions had classical ST segment elevation in respective territories. In this study, authors found that half of total circumflex artery occlusions were classified as non-ST elevation ACS when using the current 12-lead ECG criteria. This emphasizes the need for the incorporation of routine posterior leads in cases of suspected ACS if classical ST elevation is not present in 12-lead ECG. Otherwise, many patients with totally occluded culprit arteries may be denied, the revascularization procedures in their golden hour. In third original research article, Savitharani et al. have screened a total of 900 supporting staff of a Tertiary Care Hospital, Mysuru, were screened for CVD risks by utilizing WHO-ISH 10-year CVD Risk Prediction Chart. Out of them, 30 (3.3%) had hypertension, 20 (2.2%) had diabetes mellitus (DM), and 18 (1.99%) consumed tobacco. The proportion of newly detected diabetes cases was 8 (0.9%) and of prediabetics was 32 (3.7%). The proportion of newly detected prehypertensives were 292 (39.08%), and 27 (3.61%) were hypertensives. Out of 175 individuals aged above 40 years, the WHO-ISH risk prediction chart predicted that 1.7% of them had >10% risk of CVD event within 10 years.
The role of glycosylated hemoglobin (HbA1c) in predicting the outcome of ACS remains largely controversial. In fourth original research article, Singh et al. have studied the impact of higher HbA1c in predicting outcome of ACS patients. This observational cross-sectional study included 100 patients without DM, who were admitted to the coronary care unit with symptoms suggestive of ACS. This study shows that ACS patients without known DM are associated with poorer outcomes if they have higher levels of HbA1c. High normal HbA1c is associated with more complications such as left ventricular function and arrhythmia. High normal HbA1c is also associated with more severe ACS in terms of higher levels of troponin T, lower EF, presence of regional wall motion abnormalities on ECHO. At last, in Journal Watch, I have discussed the salient finding of five landmark study which will impact the future cardiovascular practice. In this issue we are publishing for the first time a book
